Sangamo showcases Fabry progress at WORLDSymposium™

Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

BRISBANE, Calif. --(BUSINESS WIRE)--Nov. 9, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences: Barclays Gene Editing & Gene Therapy Summit Date: Monday, November 15 th at 10:30